These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 4579393)

  • 41. Haloperidol in overt ambulatory schizophrenics.
    Darling HF
    Dis Nerv Syst; 1973; 34(7):364-7. PubMed ID: 4782293
    [No Abstract]   [Full Text] [Related]  

  • 42. Comparative efficacy of red cell and plasma haloperidol as predictors of clinical response in schizophrenia.
    Smith RC; Baumgartner R; Shvartsburd A; Ravichandran GK; Vroulis G; Mauldin M
    Psychopharmacology (Berl); 1985; 85(4):449-55. PubMed ID: 2862652
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Further studies on the mechanism of antipsychotic action: potentiation by alpha-methyltyrosine of thioridazine effects in chronic schizophrenics.
    Carlsson A; Roos BE; Wålinder J; Skott A
    J Neural Transm; 1973; 34(2):125-32. PubMed ID: 4146641
    [No Abstract]   [Full Text] [Related]  

  • 44. Further studies of the butyrophenone, CI-601, in chronic schizophrenic patients.
    Edwards JG; Simpson GM
    Curr Ther Res Clin Exp; 1968 Oct; 10(10):520-8. PubMed ID: 4971467
    [No Abstract]   [Full Text] [Related]  

  • 45. Therapeutic trial of lysergic Acid diethylamide (LSD) and thioridazine in chronic schizophrenia.
    Shirvaikar RV; Kelkar YW
    Neurol India; 1966; 14(2):97-101. PubMed ID: 5330728
    [No Abstract]   [Full Text] [Related]  

  • 46. Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia. Chemically unrelated antipsychotics as therapeutic alternatives.
    Serafetinides EA; Collins S; Clark ML
    J Nerv Ment Dis; 1972 Jan; 154(1):31-42. PubMed ID: 4550211
    [No Abstract]   [Full Text] [Related]  

  • 47. Haloperidol, thioridazine and placebo in mentally subnormal patients-serum levels and clinical effects.
    Väisänen K; Viukari M; Rimón R; Räisänen P
    Acta Psychiatr Scand; 1981 Mar; 63(3):262-71. PubMed ID: 7015792
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The behavioral effects of nicotinamide adenine dinucleotide in chronic schizophrenia.
    Meltzer H; Shader R; Grinspoon L
    Psychopharmacologia; 1969; 15(2):144-52. PubMed ID: 4310848
    [No Abstract]   [Full Text] [Related]  

  • 49. Flupenthixol in chronic schizophrenic inpatients: a controlled comparison with haloperidol.
    Ehmann TS; Delva NJ; Beninger RJ
    J Clin Psychopharmacol; 1987 Jun; 7(3):173-5. PubMed ID: 3298328
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A clinical study with propericiazine in chronic psychotic patients.
    Deutsch M; Ananth JV; Ban TA
    Curr Ther Res Clin Exp; 1971 Jun; 13(6):353-8. PubMed ID: 4397391
    [No Abstract]   [Full Text] [Related]  

  • 51. Lateral ventricular enlargement and clinical response in schizophrenia.
    Smith RC; Baumgartner R; Ravichandran GK; Mauldin M; Burd A; Vroulis G; Gordon J; Calderon M
    Psychiatry Res; 1985 Mar; 14(3):241-53. PubMed ID: 3858896
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Loxapine succinate: a double-blind comparison with haloperidol and placebo in acute schizophrenics.
    Selman FB; McClure RF; Helwig H
    Curr Ther Res Clin Exp; 1976 Jun; 19(6):645-52. PubMed ID: 819222
    [No Abstract]   [Full Text] [Related]  

  • 53. Plasma levels and clinical effects of thioridazine and thiothixene.
    Bergling R; Mjorndal T; Oreland L; Rapp W; Wold S
    J Clin Pharmacol; 1975; 15(2-3):178-86. PubMed ID: 1091665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thioridazine improves affective symptoms in schizophrenic patients.
    Dufresne RL; Valentino D; Kass DJ
    Psychopharmacol Bull; 1993; 29(2):249-55. PubMed ID: 8290673
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High dosage haloperidol in chronic schizophrenia.
    McCreadie RG; MacDonald IM
    Br J Psychiatry; 1977 Sep; 131():310-6. PubMed ID: 334315
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Double blind comparative study of the effects of thiothixene and thioridazine in twenty chronic schizophrenic patients.
    Hardeman WJ; Bakker SJ
    Psychiatr Neurol Neurochir; 1970; 73(1):1-7. PubMed ID: 4907371
    [No Abstract]   [Full Text] [Related]  

  • 57. A controlled study of the effects of gamfexine in phenothiazine-treated patients.
    Zimmermann RL; Vestre ND; Schiele BC; Curran J
    Curr Ther Res Clin Exp; 1970 Apr; 12(4):230-3. PubMed ID: 4985944
    [No Abstract]   [Full Text] [Related]  

  • 58. The effects of selected antipsychotic drugs of human judgment.
    Gillis JS
    Curr Ther Res Clin Exp; 1977 Feb; 21(2):224-32. PubMed ID: 403057
    [No Abstract]   [Full Text] [Related]  

  • 59. The effect of propranolol and thioridazine on positive and negative symptoms of schizophrenia.
    Eccleston D; Fairbairn AF; Hassanyeh F; McClelland HA; Stephens DA
    Br J Psychiatry; 1985 Dec; 147():623-30. PubMed ID: 3913486
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Longterm maintenance therapy with depot haloperidol in schizophrenia.
    Zbytovský J
    Homeost Health Dis; 1991; 33(5-6):287. PubMed ID: 18265499
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.